Immulina 800
✅ Boosts immune system
✅ Fights infections
✅ Reduces illness duration
✅ Enhances immune response
✅ Supports overall health
Immulina contains Pidotimod.
✓ Lékařsky ověřeno Morgan Ellis — Pharmacy Researcher · 8 years experience Last reviewed: May 2026
⚡ Quick Answer — What is Immulina 800?
Immulina 800 obsahuje pidotimod 800 mg, , synthetic dipeptide immunomodulator that enhances the body’s innate and adaptive immune response. Used as adjunct therapy for recurrent respiratory tract infections in children and adults, recurrent urinary tract infections, and asthma exacerbations driven by viral upper-respiratory infections. Pidotimod is well-established in Europe (Italy, Spain) and Asia for prevention of recurrent infections in immune-vulnerable patients. Manufactured by Glenmark Pharma.
📦 Každá objednávka je pokryta naší Zárukou opětovného odeslání — pokud vaše zásilka nedorazí do 20 pracovních dnů, přeposíláme ji.
Proč objednávat z MedsBase
Naše generické léky pocházejí od výrobců certifikovaných WHO-GMP a jsou expedovány po celém světě v diskrétním, nenápadném balení – na vnější straně balíku není uveden název léku. Platby kartou jsou směrovány prostřednictvím regulovaného procesoru (popisky na výpisu zahrnují regulovaného procesora plateb kartou – nikdy “MedsBase” nebo název léku). Přijímáme také kryptoměny a bankovní převody SEPA. Každá objednávka je zajištěna naší politikou přeposlání.
What Is Immulina 800?
Immulina 800 contains pidotimod, a synthetic dipeptide immunomodulator first introduced in Italy in the 1990s as Polimod / Adimod. It activates dendritic cells, T-helper cells, and natural killer cells — boosting antibody and cell-mediated responses to recurrent infection. Particularly studied in paediatric recurrent respiratory infection and asthma triggered by viral exacerbations.
How Does Pidotimod Work?
- Activates dendritic cells via TLR-2 — improves antigen presentation
- Enhances T-helper 1 response — favours Th1 over Th2 polarisation, useful in atopic disease where Th2 dominates
- Stimulates phagocyte function — improves bacterial clearance
- Increases natural killer cell activity
- Increases salivary IgA — improves mucosal immunity
Použití a indikace
- Recurrent upper respiratory tract infections in children and adults
- Recurrent acute exacerbations of chronic bronchitis
- Asthma with frequent viral-triggered exacerbations
- Recurrent urinary tract infection
- Allergic rhinitis with frequent infections
Immulina 800 Dosage
| Patient | Dávka | Frekvence |
|---|---|---|
| Adults | 800 mg | Once or twice daily for 60–90 days |
| Children 3–14 yr | 400 mg | Once or twice daily for 60–90 days |
| Maintenance prevention | 800 mg | 20 days per month for 3–6 months |
Vedlejší účinky
- Mild nausea, dyspepsia
- Bolest hlavy
- Dizziness
- Rarely: rash
Serious — stop and seek help:
- Severe allergic reaction
- New autoimmune symptoms (very rare; immunomodulators may unmask latent autoimmune disease)
Varování a opatření
- Active infection: use in addition to (not in place of) appropriate antibiotic or antiviral therapy.
- Autoimmune disease: caution — limited safety data; consult specialist.
- Těhotenství a kojení: limited data; avoid unless benefit clear.
- Immunosuppression: use cautiously; immunomodulator effect may be unpredictable.
Kontraindikace
- Hypersensitivity to pidotimod
- Active autoimmune disease (relative)
Interakce s léčivy
- Limited known interactions
- Theoretical: may affect immunosuppressant therapy (caution in transplant patients)
Skladování
- Store below 25°C in a cool, dry place away from direct sunlight.
- Keep in original packaging until use to protect from moisture and light.
- Do not use after the expiry date printed on the strip.
- Keep out of reach of children.
Související alternativy na MedsBase
- Asthalin Inhaler — salbutamol reliever
- Budecort Inhaler — budesonide ICS preventer
- Foracort Inhaler — budesonide + formoterol ICS-LABA
- Montair — montelukast LTRA tablet
- Tiova Inhaler — tiotropium LAMA for COPD
Často kladené dotazy
Is pidotimod evidence-based?
Pidotimod has multiple randomised trials in paediatric recurrent respiratory infection showing reduced infection rate, fewer school-day losses, and reduced antibiotic use. Evidence in adults is more mixed. It is licensed and well-established in Italy, Spain, and parts of Asia; less commonly used in the UK or US.
How long does it take to work?
Effect on infection frequency builds over 60–90 days of consistent dosing. Maintenance courses (20 days per month for 3–6 months) prevent recurrence.
Can children take Immulina 800?
Yes from age 3 — typically at 400 mg dose. The 800 mg strength is for adults and adolescents over 14.
Is Immulina an antibiotic?
No — it does not kill bacteria or viruses directly. It enhances your immune response so you fight infection more effectively. For active infections, antibiotics or antivirals are still needed.
Can I take Immulina with my asthma inhaler?
Yes — pidotimod is an adjunct in asthma with frequent viral triggers; it does not replace your inhalers.
Will it help my recurrent UTIs?
Some evidence of benefit. Discuss with your urologist or GP.
Are there any interactions?
Few known interactions. Caution in transplant patients on immunosuppressants.
Is Immulina safe in pregnancy?
Limited data; avoided unless benefit clear.
How does Immulina compare with vitamin D, zinc, or echinacea?
Pidotimod is a regulated pharmaceutical with specific RCT evidence in recurrent infection. Vitamin D is supportive (deficiency raises infection risk). Zinc may shorten cold duration. Echinacea has mixed evidence. Pidotimod is the most clinically validated of these for recurrent respiratory infection.
Související alternativy
Další produkty v Chronická onemocnění které zákazníci také prohlížejí:
More options in Asthma/COPD Treatment
Řazeno podle nedávného objemu objednávek na MedsBase — co si ostatní zákazníci v této kategorii vybírají.
| Síla | 800 mg |
|---|---|
| Množství | 10 Tablet/s, 20 Tablet/s, 30 Tablet/s, 60 Tablet/s |
Immulina 800
Otázky a odpovědi
Immulina 800
Související produkty
Hodnocení
Zatím zde nejsou žádná hodnocení